Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa

Institute of Child Health

Status and phase: Completed; Phase 4

Conditions: Epidermylosis Bullosa

Treatments: Drug: morphine sulphate in intrasite gel; Drug: topical opiod

Study type: Interventional

Funder types: Other

Identifiers

NCT00231517

01MH17

Details and patient eligibility

About

Randomised Double blind placebo controlled cross over design study of the efficacy of morphine for inflammatory pain in children with Epidermolysis Bullosa

Sex: All

Ages: 4 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• children under 18 years epidermolysis wounds requiring dressing changes

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind